Oral presentation is available to registered attendees only via the ASH annual meeting virtual platform, as per congress regulations. 

Session Name: 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Clinical Evidence in ITP 

Session Date: Monday, December 9, 2024 

Session Time: 10:30 AM - 12:00 PM 

Presentation Time: 11:45 AM Room: San Diego Convention Center, Room 29

Link to Published Abstract

Publication
  • ASH •
  • 9 December, 2024 •
  • •

Association Between Hemophilia Joint Health Score and Quality of Life Using Results from the XTEND-1 Efanesoctocog Alfa Phase 3 Trial

Christoph Königs, Doris V. Quon, Cedric Hermans, Nana Kragh, Jérôme Msihid, Emilie Gerard, Duygu Bozkaya, Linda Bystrická, Cecile LeCamus, Elena Santagostino, Annemieke Willemze, Annette von Drygalski

Publication
  • ASH •
  • 9 December, 2024 •
  • •

Real-World Paterns of Additional Factor Treatment Use Among Hemophilia A Patients on Regular Prophylaxis in the United States: Results from the PicnicHealth database

Jonathan C. Roberts, Angela Weyand, Mark Reding, Nana Kragh, Nicole Tsao, Emily Cibelli, Gillian Hanson, Duygu Bozkaya, Anne-Laure Tardy

Publication
  • ASH •
  • 9 December, 2024 •
  • •

Unmet Needs, Factor Consumption, and Healthcare Resource Use among People with Hemophilia A: Real-World Analysis of the Adelphi Hemophilia Disease Specific Programme™

Lynn Malec, Davide Matino, Kieran Wynne-Cattanach, Chris Blazos, Duygu Bozkaya, Anne-Laure Tardy, Jennifer Dumont , Sylvie Bozzi

Publication
  • ASH •
  • 8 December, 2025 •
  • •

Patient-reported outcomes of avatrombopag for chronic immune thrombocytopenia: Interim analysis of the Phase 4 adopt study

María Eva Mingot Castellano, María Teresa Álvarez Román, María Luisa Lozano, Wolfgang Miesbach, Hafiz Qureshi, Vickie McDonald, Jessica Zhang, Viridiana Cano Garcia, Nina Skuban

Publication
  • ASH •
  • 6 December, 2025 •
  • •

Real-world treatment patterns & outcomes among patients with immune thrombocytopenia (ITP) who switched treatment from eltrombopag or romiplostim to avatrombopag in the United States: Results from the real-AVA 3.5 study

Caroline Piatek, Abiola Oladapo, Scott Kolodny, Michael Vredenburg , Sarah Lucht, Emily Bland, Prathamesh Pathak, Bruce Feinberg, Hillary Maitland

Publication
  • ASH •
  • 6 December, 2025 •
  • •

Real-world safety and efficacy of avatrombopag in adults with immune thrombocytopenia: A systematic review and meta-analysis

María Luisa Lozano, David Valcarcel

Publication
  • AMCP Nexus •
  • 28 October, 2025 •
  • •

Healthcare Resource Utilization in Patients with Primary Immune Thrombocytopenia Treated with Avatrombopag in the United States: REAL-AVA 2.0 Study Results

Abiola Oladapo, Srikanth Nagalla, Moshe Y Levy, Shruti Chaturvedi, Scott Kolodny, Chelsea Bernheisel, Elyse Swallow, Debbie Goldschmidt, Alexandra Greatsinger, Loren Ormenaj, Sinia Sareen, Michael Vredenburg

Available materials

Poster
Sign up for alerts